These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 17096877)
1. Depressing the immune escape of acute myelomonocytic leukemia via an anti-Fas ribozyme. Liu LB; Li WM; Zou P; He W; Zhang M Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Oct; 14(5):862-6. PubMed ID: 17096877 [TBL] [Abstract][Full Text] [Related]
2. [Blocking the escape of leukemic cells from killing of T cell by combining anti-Fas ribozyme and CD80-IgG fusion protein]. Liu LB; Li WM; He W; Zhang M; Xiao J; Zhong ZD; Li L; Zou P Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3469-74. PubMed ID: 16686062 [TBL] [Abstract][Full Text] [Related]
3. [Experimental study of inhibiting CTLL-2 cell apoptosis and enhancing cytotoxicity to Yac-1 cell by hammerhead ribozyme]. Zhang M; Liu F; You Y; He W; Zou P; Chen ZC; Liu ZP; Liu LB Zhonghua Xue Ye Xue Za Zhi; 2004 Dec; 25(12):705-8. PubMed ID: 15730709 [TBL] [Abstract][Full Text] [Related]
4. Inhibiting apoptosis of CTLL-2 cells to enhance their GVL effects via anti-Fas ribozyme. Zhang M; Liu F; Liu LB; You Y; Chen ZC; Zou P Acta Biochim Biophys Sin (Shanghai); 2004 Aug; 36(8):559-65. PubMed ID: 15295649 [TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of anti-fas ribozyme on apoptosis of mouse T cells. Zhang M; Chen ZC; Tian L; Liu F; Liu LB; You Y; Zou P Ai Zheng; 2005 May; 24(5):520-4. PubMed ID: 15890090 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of Fas-mediated apoptosis in Yac-1 cell via Anti-Fas ribozyme. Zhang M; Liu F; He W; You Y; Zou P; Liu LB Acta Biochim Biophys Sin (Shanghai); 2004 Mar; 36(3):199-205. PubMed ID: 15202504 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of mouse hepatocyte apoptosis via anti-Fas ribozyme. Zhang M; He W; Liu F; Zou P; Xiao J; Zhong ZD; Hu ZB World J Gastroenterol; 2004 Sep; 10(17):2567-70. PubMed ID: 15300908 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of Fas-mediated apoptosis in mouse insulinoma betaTC-3 cells via an anti-Fas ribozyme. Klein D; Ricordi C; Pugliese A; Pastori RL Hum Gene Ther; 2000 May; 11(7):1033-45. PubMed ID: 10811232 [TBL] [Abstract][Full Text] [Related]
9. [Expression of immune response molecules and function of fas ligand on surface of AML WEHI-3 cells]. Liu LB; Li WM; He W; Zou P Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):535-8. PubMed ID: 16800937 [TBL] [Abstract][Full Text] [Related]
10. Reduction of CTLL-2 cytotoxicity by induction of apoptosis with a Fas-estrogen receptor chimera. Kametaka M; Kume A; Okada T; Mizukami H; Hanazono Y; Ozawa K Cancer Sci; 2003 Jul; 94(7):639-43. PubMed ID: 12841875 [TBL] [Abstract][Full Text] [Related]
11. Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killing. Rivoltini L; Radrizzani M; Accornero P; Squarcina P; Chiodoni C; Mazzocchi A; Castelli C; Tarsini P; Viggiano V; Belli F; Colombo MP; Parmiani G J Immunol; 1998 Aug; 161(3):1220-30. PubMed ID: 9686582 [TBL] [Abstract][Full Text] [Related]
12. Effects of anti-HPV16 E6-ribozyme on the proliferation and apoptosis of human cervical cancer cell line CaSKi. Zheng YF; Rao ZG; Zhang JR Di Yi Jun Yi Da Xue Xue Bao; 2002 Jun; 22(6):496-8. PubMed ID: 12297466 [TBL] [Abstract][Full Text] [Related]
13. Efficient ex vivo inhibition of perforin and Fas ligand expression by chimeric tRNA-hammerhead ribozymes. Du Z; Ricordi C; Inverardi L; Podack E; Pastori RL Hum Gene Ther; 1998 Jul; 9(11):1551-60. PubMed ID: 9694154 [TBL] [Abstract][Full Text] [Related]
14. Immunosensitization of prostate carcinoma cell lines for lymphocytes (CTL, TIL, LAK)-mediated apoptosis via the Fas-Fas-ligand pathway of cytotoxicity. Frost P; Ng CP; Belldegrun A; Bonavida B Cell Immunol; 1997 Aug; 180(1):70-83. PubMed ID: 9316641 [TBL] [Abstract][Full Text] [Related]
15. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape? Ni X; Hazarika P; Zhang C; Talpur R; Duvic M Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580 [TBL] [Abstract][Full Text] [Related]
16. Suppression of FasL expression in tumor cells and preventing tumor necrosis factor-induced apoptosis by adenovirus 14.7K is an effective escape mechanism for immune cells. Zhang J; Xu G Cancer Genet Cytogenet; 2007 Dec; 179(2):112-7. PubMed ID: 18036397 [TBL] [Abstract][Full Text] [Related]
17. Prolonged survival of pig islets xenograft by adenovirus-mediated expression of either the membrane-bound human FasL or the human decoy Fas antigen gene. Kawamoto K; Tanemura M; Ito T; Deguchi T; Machida T; Nishida T; Doki Y; Mori M; Sawa Y Xenotransplantation; 2008; 15(5):333-43. PubMed ID: 19134163 [TBL] [Abstract][Full Text] [Related]
18. Spontaneous in vivo retrovirus-infected T and B cells, but not dendritic cells, mediate antigen-specific Fas ligand/Fas-dependent apoptosis of anti-retroviral CTL. Rich RF; Cook WJ; Green WR Virology; 2006 Mar; 346(2):287-300. PubMed ID: 16337984 [TBL] [Abstract][Full Text] [Related]
19. Expression of FasL by tumor cells does not abrogate anti-tumor CTL function. Lee SH; Bar-Haim E; Goldberger O; Reich-Zeliger S; Vadai E; Tzehoval E; Eisenbach L Immunol Lett; 2004 Feb; 91(2-3):119-26. PubMed ID: 15019279 [TBL] [Abstract][Full Text] [Related]
20. [Study on blocking the tumor immune escape by Fas ligand pathway]. Hu ZB; Zou P; Li AX; Wang LL; Liu LB Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):616-21. PubMed ID: 14706146 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]